Stock MVMD MOUNTAIN VALLEY MD HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Mountain Valley MD Holdings Inc.

Equities

MVMD

CA62430M1014

Pharmaceuticals

Market Closed - Canadian Securities Exchange
Other stock markets
 02:29:51 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.055 CAD 0.00% Intraday chart for Mountain Valley MD Holdings Inc. 0.00% +37.50%
Mar. 01 Mountain Valley MD Holdings Inc. Plans to Introduce Soluvec 1% Coated Fish Feed in Bangladesh by May of 2024 CI
Mar. 01 Mountain Valley MD Holdings Inc. Provides Update on Agrarius Trial Results CI

Valuation

Fiscal Period: März 2020 2021 2022 2023
Capitalization 1 14.62 388.3 56.95 19.78
Enterprise Value (EV) 1 13.43 368.9 42.77 10.07
P/E ratio -0.66 x -38.5 x -5.09 x -2.66 x
Yield - - - -
Capitalization / Revenue - - 517,687,873 x -
EV / Revenue - - 388,806,055 x -
EV / EBITDA -4,361,444 x -77,260,005 x -4,583,503 x -1,972,426 x
EV / FCF -18,809,953 x -128,879,352 x -21,365,638 x -3,582,306 x
FCF Yield -0% -0% -0% -0%
Price to Book 1.71 x 13.2 x 2.29 x 1.22 x
Nbr of stocks (in thousands) 243,691 326,288 379,638 329,653
Reference price 2 0.0600 1.190 0.1500 0.0600
Announcement Date 9/29/20 7/29/21 7/13/22 7/12/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2019 2020 2021 2022 2023
Net sales - - - 0.11 -
EBITDA - -3.08 -4.774 -9.331 -5.106
EBIT 1 -2.129 -3.141 -5.162 -9.742 -5.551
Operating Margin - - - -8,856.36% -
Earnings before Tax (EBT) 1 -2.153 -18.84 -8.143 -9.709 -7.333
Net income 1 -2.153 -18.84 -8.143 -9.709 -7.442
Net margin - - - -8,826.36% -
EPS 2 -0.0240 -0.0904 -0.0309 -0.0295 -0.0226
Free Cash Flow - -0.7142 -2.862 -2.002 -2.811
FCF margin - - - -1,819.77% -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 9/26/19 9/29/20 7/29/21 7/13/22 7/12/23
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 8.81 1.19 19.4 14.2 9.71
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - -0.71 -2.86 -2 -2.81
ROE (net income / shareholders' equity) - -193% -39.2% -35.1% -36.3%
ROA (Net income/ Total Assets) - -16.6% -14.7% -21.4% -16.5%
Assets 1 - 113.9 55.32 45.35 45.09
Book Value Per Share 2 0.0600 0.0400 0.0900 0.0700 0.0500
Cash Flow per Share 2 0.0500 0.0100 0.0600 0.0400 0.0300
Capex - 0.06 0.33 - -
Capex / Sales - - - - -
Announcement Date 9/26/19 9/29/20 7/29/21 7/13/22 7/12/23
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Alternative Medicine

1st Jan change Capi.
MOUNTAIN VALLEY MD HOLDINGS INC. Stock Mountain Valley MD Holdings Inc.
+37.50% 13.24M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+35.04% 5.92B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.13% 4.51B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.75% 3.15B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+2.14% 3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-6.82% 2.42B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+47.87% 1.97B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-7.89% 1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+0.09% 1.65B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-12.97% 1.53B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. MVMD Stock
  4. Financials Mountain Valley MD Holdings Inc.